Gaussion Secures $28 Million in Latest Series A Funding Round

Gaussion secured $28 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Gaussion Raises $28 million in Funding

Gaussion Raises $28M in Funding. Founded in 2022 as a spinout from University College London and the Faraday Institution, the UK’s flagship battery research program, and led by CEO and co-founder Tom Heenan, Gaussion develops MagLiB™, a magnetic PCB retrofit system, and Aeon™, a proprietary control chip and over-the-air intelligence platform that together create an intelligent control layer inside battery packs.

Investors Behind the Funding

The round was backed by BGF. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Gaussion operates in Healthcare & Life Sciences. Gaussion's financing adds to recent private-market activity.

Strategic Use of Funds

Over $44m since the company was founded in 2022, was co-led by BGF and AlbionVC, with follow-on participation from Autotech Ventures, UCL Technology Fund, DN Capital and Future Ven.

Looking Ahead

Gaussion Raises $28M in Funding

Source reference: original announcement/article.